Basic Information
Basic information for ITGA9-AS1-231-45aa
Peptide Name ITGA9-AS1-231-45aa
Genome Position chr3:37716907-37716945,37749569-37749664[-]
Species Human
Peptide Sequence MEVTETSKSKEGEEKAEHETRGRNRICRGIKKADGKLNKWGPPLK
Peptide Length 45
Unique No (ITGA9-AS1-221-45aa,ITGA9-AS1-230-45aa)
Grand Average of Hydropathicity -1.52
Relative Molecular Mass 5916.6
Experimental Evidences no
lncRNA ID/Name ENSG00000235257;ITGA9-AS1
Transcript ID/Name ENST00000663533;ITGA9-AS1-231
Transcript Length 3917
Coding Ability 0.457
DNA Sequence Corresponding to Peptide ATGGAGGTCACAGAGACCAGTAAGAGCAAGGAGGGAGAGGAAAAAGCTGAACATGAAACTCGAGGAAGAAACAGAATATGCAGAGGAATAAAAAAAGCTGACGGAAAACTCAACAAGTGGGGACCTCCCCTGAAA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :